BIAF (bioAffinity Technologies, Inc. Common Stock) Stock Analysis - SEC Filings

bioAffinity Technologies, Inc. Common Stock (BIAF) is a publicly traded Healthcare sector company. As of May 21, 2026, BIAF trades at $1.68 with a market cap of $7.64M and a P/E ratio of -0.24. BIAF moved -2.94% today. Year to date, BIAF is +32.80%; over the trailing twelve months it is -81.06%. Its 52-week range spans $0.69 to $67.12. Rallies surfaces BIAF's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find BIAF SEC filings?

Rallies organizes BIAF SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

BIAF Key Metrics

Key financial metrics for BIAF
MetricValue
Price$1.68
Market Cap$7.64M
P/E Ratio-0.24
EPS$-6.83
Dividend Yield0.00%
52-Week High$67.12
52-Week Low$0.69
Volume174.14K
Avg Volume0
Revenue (TTM)$5.66M
Net Income$-15.88M
Gross Margin0.00%

Latest BIAF News

BIAF Analyst Consensus

BIAF analyst coverage data. Average price target: $0.00.

Common questions about BIAF

Where can I find BIAF SEC filings?
Rallies organizes BIAF SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show BIAF 10-K and 10-Q filings?
Rallies organizes BIAF SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is BIAF research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BIAF. It does not provide personalized investment advice.
BIAF

BIAF